Register Login

Novocure Ltd (NVCR)

(85% Positive) Novocure Ltd (NVCR) Announces Enrollment Update for updates Due to Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review

Full text
Register to leave comments
  • News bot Jan. 29, 2026, 8:54 p.m.

    📋 Novocure Ltd (NVCR) - Clinical Trial Update

    Filing Date: 2026-01-12

    Accepted: 2026-01-12 07:00:46

    Event Type: Clinical Trial Update

    Event Details:

    Novocure Ltd (NVCR) Announces Clinical Trial Update Novocure Ltd (NVCR) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: updates, revenues
    • Collaboration: J.P. Morgan Healthcare Conference
    • Updated Timeline: the year and fourth quarter ended December 31, 2025, the quarter and full year ended December 31, 2025

    🔬 Clinical Development Pipeline (Novocure Ltd):

    Product Type Development Stage Therapeutic Area Source
    Tumor Treating Fields Therapy DEVICE Phase PHASE2 Extensive Stage Lung Small Cell Carcinoma ClinicalTrials.gov
    TTFields Therapy DEVICE Phase PHASE2 Glioblastoma ClinicalTrials.gov
    TTFields DEVICE Preclinical Glioblastoma ClinicalTrials.gov
    Temozolomide DRUG Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Electric Field Therapy PROCEDURE Phase PHASE2 Adult Brain Glioblastoma ClinicalTrials.gov
    Tumor Treating Fields (TTF) DEVICE Approved Pancreas Cancer ClinicalTrials.gov
    nab paclitaxel DRUG Phase PHASE3 Pancreas Adenocarcinoma ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE3 Pancreas Adenocarcinoma ClinicalTrials.gov
    NovoTTF-200T DEVICE Phase PHASE3 Pancreas Adenocarcinoma ClinicalTrials.gov
    Stereotactic Ablative Body Radiation (SABR) RADIATION Approved Pancreas Cancer ClinicalTrials.gov
    Planned surgical resection PROCEDURE Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Optune DEVICE Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Niraparib DRUG Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Pembrolizumab DRUG Phase PHASE1 Metastatic Melanoma ClinicalTrials.gov
    NovoTTF-200A DEVICE Phase PHASE1 Metastatic Melanoma ClinicalTrials.gov
    Stereotactic radiosurgery (SRS) RADIATION Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Gadolinium DRUG Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Optune System DEVICE Phase PHASE2 Glioblastoma ClinicalTrials.gov
    Temozolomide (TMZ) DRUG Phase PHASE2 Glioblastoma ClinicalTrials.gov
    TTF-200M and TTF-200A systems DEVICE Phase PHASE1 Spinal Metastasis ClinicalTrials.gov
    NovoTTF-200T System DEVICE Approved NSCLC ClinicalTrials.gov
    NovoTTF-100L DEVICE Phase PHASE1 Non-small Cell Lung Cancer ClinicalTrials.gov
    NovoTTF-100A DEVICE Phase PHASE3 Recurrent Glioblastoma Multiforme ClinicalTrials.gov
    Best Standard of Care OTHER Phase PHASE2 1-5 Brain Metastases From Non-Small Cell Lung Cancer ClinicalTrials.gov
    NovoTTF-100A device DEVICE Phase PHASE2 1-5 Brain Metastases From Non-Small Cell Lung Cancer ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE1 Ovarian Carcinoma ClinicalTrials.gov
    NovoTTF-100L(O) DEVICE Phase PHASE1 Ovarian Carcinoma ClinicalTrials.gov
    nab-Paclitaxel DRUG Phase PHASE1 Pancreatic Adenocarcinoma ClinicalTrials.gov
    Quality-of-Life Assessment OTHER Phase PHASE2 Adult Brain Glioblastoma ClinicalTrials.gov
    Carmustine DRUG Phase PHASE2 Adult Brain Glioblastoma ClinicalTrials.gov
    Bevacizumab BIOLOGICAL Phase PHASE2 Adult Brain Glioblastoma ClinicalTrials.gov
    Cisplatin or Carboplatin DRUG Phase PHASE2 Malignant Pleural Mesothelioma ClinicalTrials.gov
    Pemetrexed DRUG Phase PHASE2 Malignant Pleural Mesothelioma ClinicalTrials.gov
    NovoTTF-100L device DEVICE Phase PHASE2 Malignant Pleural Mesothelioma ClinicalTrials.gov
    NovoTTF-200A Device DEVICE Approved Extensive Stage Small Cell Lung Carcinoma ClinicalTrials.gov
    Tumor Treating Fields (TTF) Therapy PROCEDURE Approved Extensive Stage Small Cell Lung Carcinoma ClinicalTrials.gov
    Radiotherapy RADIATION Approved Glioblastoma Multiforme ClinicalTrials.gov
    Optune TTF device DEVICE Approved Central Nervous System Neoplasms, Primary ClinicalTrials.gov
    Craniectomy PROCEDURE Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Carvedilol DRUG Phase EARLY_PHASE1 Glioblastoma ClinicalTrials.gov
    NovoTTF DEVICE Preclinical Malignant Glioma ClinicalTrials.gov
    Wear novoTTF-200A DEVICE Approved Anaplastic Oligodendroglioma ClinicalTrials.gov
    LCR Meter (Brand: Keysight, Serial Number:E498AL) DEVICE Approved Lung Cancer ClinicalTrials.gov
    Optune(NOVOTTF-100A) DEVICE Approved RECURRENT GLIOBLASTOMA ClinicalTrials.gov
    Quality of Life Questionnaires OTHER Phase PHASE2 Glioblastoma Multiforme ClinicalTrials.gov
    Brain MRI OTHER Phase PHASE2 Glioblastoma Multiforme ClinicalTrials.gov
    Ipilimumab BIOLOGICAL Phase PHASE2 Melanoma With Brain Metastasis ClinicalTrials.gov
    Nivolumab BIOLOGICAL Phase PHASE2 Melanoma With Brain Metastasis ClinicalTrials.gov
    Laboratory biomarker analysis GENETIC Approved Glioblastoma ClinicalTrials.gov
    NovoTTF100A DEVICE Phase PHASE2 Cancer of Brain and Nervous System ClinicalTrials.gov
    Questionnaire Administration OTHER Phase PHASE2 Extensive Stage Lung Small Cell Carcinoma ClinicalTrials.gov
    Radiation Therapy RADIATION Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Tumor Treating Fields DEVICE Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Trastuzumab DRUG Approved Gastric Cancer ClinicalTrials.gov
    Capecitabine DRUG Approved Gastric Cancer ClinicalTrials.gov
    Oxaliplatin DRUG Approved Gastric Cancer ClinicalTrials.gov
    NovoTTF-100L(P) DEVICE Approved Gastric Cancer ClinicalTrials.gov
    Peptides BIOLOGICAL Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Poly-ICLC DRUG Phase PHASE1 Glioblastoma ClinicalTrials.gov
    Quality of Life Assessment OTHER Phase PHASE2 Adult Giant Cell Glioblastoma ClinicalTrials.gov
    NovoTTF-l00A DEVICE Phase PHASE2 Adult Giant Cell Glioblastoma ClinicalTrials.gov
    Atezolizumab DRUG Phase PHASE2 Metastatic Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    3D conformal or intensity modulated radiation therapy (IMRT) RADIATION Phase PHASE1 Glioblastoma, Adult ClinicalTrials.gov
    The samples described below will be collected: OTHER Approved Glioblastoma ClinicalTrials.gov
    Optune® DEVICE Approved Glioblastoma Multiforme ClinicalTrials.gov
    Stereotactic Radiosurgery RADIATION Phase PHASE1 Clinical Stage IV Cutaneous Melanoma AJCC v8 ClinicalTrials.gov
    Sorafenib DRUG Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    NovoTTF-100L(P) device DEVICE Phase PHASE2 Hepatocellular Carcinoma ClinicalTrials.gov
    Optune NovoTTF-200A System DEVICE Phase PHASE1 High Grade Glioma ClinicalTrials.gov
    Optune System (NovoTTF-200A System, Tumor Treating Fields, TTFields) DEVICE Approved Malignant Glioma ClinicalTrials.gov
    Yervoy DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    Opdivo DRUG Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    Novocure Optune DEVICE Phase PHASE1 Uveal Melanoma ClinicalTrials.gov
    Optune (NovoTTF-100A) DEVICE Approved Brain Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Novocure Ltd
    • Ticker Symbol: NVCR

Search

News categories